Astrazeneca (AZN) P/E (2006 - 2026)
Astrazeneca (AZN) P/E from Mar 31, 2006 to Jul 21, 2026. The TTM Astrazeneca (AZN) P/E is 25.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Astrazeneca (AZN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 25.44 | -9.36% |
| 2025 | 28.06 | -3.45% |
| 2024 | 29.07 | -18.44% |
| 2023 | 35.64 | -65.69% |
| 2022 | 103.85 | -75.74% |
| 2021 | 428.01 | +942.20% |
| 2020 | 41.07 | -57.45% |
| 2019 | 96.51 | +116.11% |
| 2018 | 44.66 | +80.01% |
| 2017 | 24.81 | -11.55% |
| 2016 | 28.05 | -7.75% |
| 2015 | 30.40 | -57.82% |
| 2014 | 72.09 | +147.88% |
| 2013 | 29.08 | +204.45% |
| 2012 | 9.55 | +50.23% |
| 2011 | 6.36 | -23.52% |
| 2010 | 8.31 | -8.12% |
| 2009 | 9.05 | -7.36% |
| 2008 | 9.77 | -14.63% |
| 2007 | 11.44 | -36.94% |
| 2006 | 18.14 | N/A |
Comparison Astrazeneca (AZN) P/E with competitors
Astrazeneca (AZN) P/E is 25.44.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -60.26% |
| PFE | Pfizer Inc | 11.65 | -54.19% |
| NVO | Novo Nordisk | 11.79 | -53.65% |
| GSK | GSK Plc | 12.10 | -52.42% |
| SNY | Sanofi | 12.12 | -52.34% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -45.67% |
| OGN | Organon & Company | 14.33 | -43.68% |
| BIIB | Biogen Inc | 17.41 | -31.58% |
| GILD | Gilead Sciences Inc | 17.75 | -30.24% |
| NVS | Novartis AG | 21.60 | -15.10% |
| JNJ | Johnson & Johnson | 22.09 | -13.17% |
| AMGN | AMGEN Inc | 24.75 | -2.70% |
| MRK | Merck & Co Inc | 26.93 | +5.85% |
| LLY | Lilly(Eli) & Company | 48.44 | +90.43% |
| ABBV | Abbvie Inc | 139.08 | +446.74% |